CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS.
D001007:Anxiety; D001921:Brain; D001925:Brain Damage, Chronic; D002072:Butylene Glycols; D002219:Carbamates; D006801:Humans; D001523:Mental Disorders; D011618:Psychotic Disorders; D012559:Schizophrenia
D002072:Butylene Glycols; D002219:Carbamates; C554304:hydroxyphenamate
ANXIETY; BRAIN DAMAGE, CHRONIC; HYDROXYPHENAMATE; SCHIZOPHRENIA